Live Chat

交易 Bristol Myers BMY

出售
 买入

BristolMyers 实时图表

5m 15m 30m 1h 4h 1d 1w

金融票据基础知识

Weekly Search
Weekly
Daily
日期 关闭 更改 更改(%)： 开盘价 高 低

最新新闻

Frances Wang 2024 Dec 09, 16:00

NASDAQ IBIT: how high will iShares Bitcoin Trust ETF go?

Cryptocurrencies ETFs
Frances Wang 2024 Dec 09, 16:00

What stocks will boom in 2025: Nasdaq potential stock analysis

Stocks
Frances Wang 2024 Dec 09, 16:00

Bitcoin over $100K: will bitcoin ETFs surge too?

Cryptocurrencies
EURUSD challenges
Dyogenes Diniz 2024 Dec 08, 17:00

Morning Note: US and Europe: PMI Data, Index Trends, and EURUSD Analysis

EUR USD S&P 500
Frances Wang 2024 Dec 08, 16:00

Fed rate cut probability in December rises: Bitcoin Reacts to U.S. Jobs Data

Cryptocurrencies
Dyogenes Diniz 2024 Dec 05, 16:00

Week ahead: Inflation and Interest rates to shake the Markets this week

Indices Forex
Frances Wang 2024 Dec 04, 16:00

Tesla stock dropped on the rejection of Elon Musk's compensation package

Stocks
Frances Wang 2024 Dec 04, 16:00

Invesco QQQ stock price today: up 0.9% during mid-day trading

Stocks Shares

信息

点差

0.36

点差(%)

0.6211 %

杠杆

1:10

隔夜利息（买入）

-0.0597 %

隔夜利息（卖出）

-0.0292 %

币种

USD

交易时间

市场关闭

星期三

14:31 - 20:59

星期一

14:31-20:59

星期二

14:31-20:59

星期四

14:31-20:59

星期五

14:31-20:59

分析和统计

开盘价

---

昨收

---

52 周高点/低点

--- – ---

市值

120433328128

在外流通股份

2028179968

财报日（下一）

2001-08-07

股息收益率

2024-11-01

除息日

2024-10-04

远期年度股息率

2.4

远期年股息率

0.0404

每股收益

-3.58

详细了解此金融票据

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

相关金融票据

资产
出售
买入
更改(%)：

立即交易

立即交易

立即交易

立即交易
相关金融票据
Trustpilot
Live Chat